** Shares of dental products manufacturer Align Technology ALGN.O slump 34.7% at $133 after the bell
** ALGN Q2 revenue down 1.6% at $1.01 billion, misses estimates of $1.06 billion, as per data compiled by LSEG
** "Believe (Q2 results) was impacted in part by U.S. tariff turmoil in and outside of U.S. and less affordable financing options for orthodontic treatment, as well as for capital equipment purchases," CEO Joe Hogan says
** Expects 2025 Clear Aligner volume growth to be in low-single digits from last year vs. prior forecast of roughly mid-single-digit growth
** Sees one-time charges between $150 million and $170 million in second half, primarily for the write-down of assets, accelerated depreciation expense, and restructuring charges
** Records adjusted quarterly net income of $2.49 per share, below $2.41 per share last year
** So far this year, stock down 2.4% as of last close
(Reporting by Savyata Mishra in Bengaluru)
((Savyata.Mishra@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.